Home » Volumes » Volume 46 November/December 2013 » Dengue infection in children and adolescents: Clinical profile in a reference hospital in northeast Brazil

Dengue infection in children and adolescents: Clinical profile in a reference hospital in northeast Brazil

Roberto da Justa Pires Neto[1] , [2] Saulo Lacerda Borges de Sá[1] Stella Catunda Pinho[3] Felícia Holanda Pucci[3] Cristiana Rodrigues Teófilo[3] Priscila Dourado Evangelista[3] Camila Silva Thé[3] Daniel Eduardo Garcia Bezerra[3] Juliana Cynara Santos Lima[3] Henrique Jorge Ponte[3] Elizabeth De Francesco Daher[4] Ivo Castelo Branco Coelho[5]

[1]Departamento de Saúde Comunitária, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE [2]Hospital São José de Doenças Infecciosas, Secretaria de Estado da Saúde, Fortaleza, CE [3]Curso de Medicina, Universidade de Fortaleza, Fortaleza, CE [4]Departamento de Medicina Clínica, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE [5]Departamento de Patologia e Medicina Legal, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE

DOI: 10.1590/0037-8682-1716-2013


ABSTRACT

Introduction

This study aimed to describe the clinical spectrum of dengue in children and adolescents from a hyperendemic region who were admitted for hospitalization.

Methods

A retrospective study was conducted on patients diagnosed with dengue infection upon admission to a reference center in Fortaleza, Brazil.

Results

Of the 84 patients included, 42 underwent confirmatory testing. The main symptoms were fever, abdominal pain and vomiting. The median level of serum aspartate aminotransferase was 143.5±128mg/dL.

Conclusions

A peculiar clinical profile was evident among children and adolescents with dengue infection in a reference center in northeast Brazil, including gastrointestinal symptoms and liver involvement.

Key words: Dengue fever; Dengue hemorrhagic fever; Clinical profile

Dengue infection represents a public health problem for urban populations in the tropical and subtropical areas of the world. Brazilians have been affected by serious dengue infections. In recent years, more than 4 million cases have been reported in all 5 Brazilian geographic regions1. Although the adult segment is the most affected, dengue infection in children has increased in recent years. This finding suggests that the clinical and epidemiological profiles of dengue have changed and reflects a stronger relationship between its most serious forms and younger age groups2,3.

The aim of this study was to describe the clinical spectrum of dengue in children and adolescents living in hyperendemic regions in Brazil who were admitted for hospitalization in a reference center.

This retrospective study took place in Fortaleza (metropolitan area in northeast Brazil) at the Hospital São José de Doenças Infecciosas (HSJDI), the main health care provider for infectious diseases. The study protocol was reviewed and approved by the institution’s Ethics Committee (Protocol number 042/2006).

Medical records were reviewed for all patients aged less than 18 years who were admitted to the HSJDI between January 2006 and December 2007 with a diagnosis of dengue infection upon either admission or discharge. An initial diagnosis of dengue infection was defined as a physician’s presumptive diagnosis upon admission to the hospital. The final diagnosis was made by the attending physician upon discharge.

Patients with suspected dengue infection were classified further into 2 groups, dengue fever (DF) or dengue hemorrhagic fever and/or dengue shock syndrome (DHF/DSS), according to all available clinical and laboratory data and based on the World Health Organization (WHO) criteria for dengue classification4. Based on the definitions proposed by the Brazilian Ministry of Health, a third patient group was classified as dengue infection with complications (DIC)5. Confirmed cases of DF, DHF/DSS, or DIC were defined based on the respective clinical profiles along with serological evidence of acute dengue infection (anti-DENV IgM antibody capture assay).

In total, 252 patients were admitted to the HSJDI with suspected dengue infection. We reviewed the medical records of the 84 (33.3%) patients who were aged 18 years or less. Of the 84 patients, 42 (50%) underwent confirmatory testing, and serological evidence of acute dengue infection was observed in 32 (76.1%) patients.

The demographic data are displayed in Table 1. Fourteen (16.6%) patients had not received prior institutional care for their illnesses and 57 (67,8%) patients had passed through at least 1 primary or secondary level health unit prior to admission to the HSJDI.

TABLE 1 – Demographics of children and adolescents hospitalized with suspected dengue infection. 

Parameters Number = 84 Percentage
Gender
 male 43 51.2
 female 41 48.8
Age (years)
 0-2 13 15.5
 3-5 13 15.5
 6-8 23 27.3
 9-11 11 13.1
 12-14 13 15.5
 15-17 11 13.1
City of residence
 Fortaleza 50 59.5
 other 34 40.5

Presumptive diagnosis of dengue infection upon admission was established for 80 (95.2%) of the 84 patients. The remaining 4 patients were presumed to have or were confirmed with a diagnosis of dengue infection upon hospital discharge. DHF/DSS was suspected in 43 (51.2%) patients upon admission. Among the 32 patients with confirmed dengue infection, 14 (43.7%) patients were observed to have DF, and 18 (56.3%) patients were observed to have DHF/DSS, according to the classification of clinical forms of dengue infection that was established upon discharge. No patients were observed to have DIC. The mean time period between the onset of symptoms and hospital admission was 6.3 ± 2.2 days for the patients with confirmed dengue infection. The main signs and symptoms presented by these patients upon admission are summarized in Table 2.

TABLE 2 – Clinical findings of children and adolescents hospitalized with confirmed dengue infection diagnosis. 

Parameters Number Percentage
Fever 32 100.0
Abdominal pain 24 75.0
Prostration 23 71.8
Vomiting 23 71.8
Rash 22 68.7
Hemorrhagic manifestation 21 65.6
Headache 20 62.5
Muscle pain 20 62.5
Hepatomegaly 12 37.5
Ocular pain 10 31.2
Pleural effusion 10 31.2
Ascites 9 28.1
Diarrhea 9 28.1
Edema 7 21.8
Joint pain 3 9.3

Of the 32 patients with confirmed dengue infection, 24 (75%) exhibited platelet counts below 100,000/mm3, and 7 (21.8%) had an initial hematocrit measurement above 42% upon admission. Of the 32 patients with confirmed dengue infection, 30 patients were tested at least once for serum albumin; of these, 22 (77.3%) had hypoalbuminemia (albumin <3.5g/dL).

Of the 84 patients with suspected dengue infection upon admission, 80 patients had at least 1 measurement of serum aminotransferases (aspartate aminotransferase [AST] and alanine aminotransferase [ALT]). The mean levels of serum AST were 143.5±128mg/dL in patients positive for IgM and 72.1±66.5mg/dL in patients negative for either IgM or with other pathologies. The mean levels of serum ALT were 68.1±65.8mg/dL for patients with positive IgM and 55.7±68.3mg/dL for patients negative for IgM or with other pathologies. The serum aminotransferases were analyzed in all 32 patients with confirmed dengue infection. The proportions of patients with serum AST> 40 mg/dL and serum ALT> 40mg/dL were 96.6% and 70%, respectively.

The tourniquet test was performed on 25 (29.7%) of the 84 patients admitted for suspected dengue infection and was positive in 17 (68%) patients. Among the 32 patients with confirmed dengue infection, the tourniquet test was performed on 11 patients and was positive in 9 (81.8%) patients.

Out of all 84 patients who were admitted with suspected dengue infection, 13 (15.4%) patients received a transfusion of at least 1 blood-based product. Two patients received plasma, 4 received platelets, and 7 received packed red blood cells. Of these 13 patients, 5 patients received more than 1 transfusion. Of the 32 patients with confirmed dengue infection, 7 (21.9%) patients received a transfusion of at least 1 blood-based product, 2 patients received plasma, 3 patients received platelets, and 2 patients received packed red blood cells. Of these 7 patients, 2 patients required more than 1 transfusion.

Table 3 lists the concordance data between the 2 different classification systems for dengue infection based on either medical diagnosis upon discharge or the WHO definitions. Of the 18 patients with confirmed DHF/DSS infection, 11 (61.1%) patients were classified in agreement with the WHO definitions. An additional 7 DHF/DSS cases would have been classified as DF based on the WHO definitions. Moreover, 6 of the 14 patients with confirmed DF infection were classified in agreement with the WHO definitions. Finally, 8 DF patients would have been classified as DHF/DSS or DIC according to the WHO definitions.

TABLE 3 – Classification of children and adolescents hospitalized with confirmed dengue infection according to both medical diagnosis upon discharge and WHO definitions. 

Parameters DF DHF DIC Total
n % n % n % n %
Concordance with WHO 6 42.8 11 61.1 0 0.0 17 53.1
Non-concordance with WHO 8 57.2 7 38.9 0 0.0 15 46.9
Total (medical diagnosis) 14 43.7 18 56.3 0 0.0 32 100.0

DF: dengue fever; DHF: dengue hemorrhagic fever; DIC: dengue infection with complications; WHO: World Health Organization.

Of the 84 patients evaluated, 2 patients required treatment in the intensive care unit, 78 patients were discharged, and 6 patients were transferred to other hospitals. Of the 32 cases confirmed serologically, 31 patients were discharged, and 1 patient was transferred. No deaths occurred.

This study presents a detailed description of the clinical manifestations of dengue infection in children and adolescents who were admitted to an infectious disease reference hospital in northeast Brazil. As information regarding the clinical manifestations of dengue infection in the Brazilian pediatric population is scarce in the literature, these findings are important2,3,6. Moreover, most dengue infections that occur in children and adolescents in a community setting manifest as asymptomatic or oligosymptomatic7.

In this study, the main, initial clinical signs and symptoms presented by children and adolescents hospitalized with confirmed dengue infection were fairly nonspecific, as was demonstrated in other studies7,8.

The gastrointestinal symptoms were remarkable in the children and adolescents analyzed in this study. These findings are similar to a retrospective study originating from Delhi, India, where 134 hospitalized children with clinically suspected dengue infection demonstrated abdominal pain (49%) and vomiting (68%) as common symptoms9.

Bleeding manifestations were observed in the majority of children and adolescents with confirmed dengue infection in this study. Hayes et al.10 evaluated 517 patients with confirmed dengue infection from a hospital in Manila, Philippines, and observed that most (78%) patients were aged less than 15 years (only 3 infants), and some type of hemorrhagic finding had occurred in 460 (89%) cases. Among these patients with bleeding manifestations, only 110 patients were observed to have DHF, whereas the rest were observed to have DF with hemorrhagic manifestations. Gastrointestinal bleeding was present in 65 cases, but only 2 patients developed shock, and no fatalities occurred. Kabra et al.11 evaluated children and adolescents who were admitted in a hospital in India with a clinical diagnosis of dengue infection. They observed that in dengue shock syndrome patients, hematemesis was present in 55 (49%) patients, epistaxis in 39 (35%) patients, melena in 27 (24%) patients, and ecchymosis in 34 (30%) patients. Another study originating in Jaipur, India, included a total of 948 children who were hospitalized at a tertiary care center with a dengue diagnosis. Bleeding manifestations were observed in 44.5% of these cases. A positive tourniquet test was the most common manifestation and was observed in 300 (31.6%) cases, whereas bleeding was the only manifestation in 9.2% of the cases. The most common spontaneous bleeding manifestation was epistaxis (25%)12. As observed in our study and reported in the literature, bleeding manifestations in children and adolescents with dengue infection may vary according to geographic regions.

Laboratory parameters that are used regularly to evaluate plasma leakage in dengue infection yielded distinct results in this study. Only 21.8% of children and adolescents with confirmed dengue infection had initial hematocrit measurements above 42% at admission, whereas 77.3% presented with hypoalbuminemia.

Remarkable liver involvement was observed in this study. These data are similar to the results described by Mohan et al.13, with the exception of jaundice. Mohan et al. evaluated the hepatic function of 61 children who were diagnosed with dengue infection. Hepatomegaly was observed in 74% of the cases and jaundice in 25% of cases. Upon admission, the levels of AST, ALT, and serum alkaline phosphatase were elevated in 87% of children with hepatomegaly and in 81% of children without hepatomegaly. Hepatic dysfunction is a well-recognized feature of dengue infection and often manifests as hepatomegaly and mild to moderate increases in transaminase levels; jaundice and acute liver failure generally occur less commonly14. Kabra et al.11 evaluated 240 children aged between 4 months and 13 years who were admitted to a hospital in India with a clinical diagnosis of dengue infection. The authors observed that unusual clinical features such as jaundice were present in 7 (6%) cases, and hepatic encephalopathy was observed in 6 (5%) cases. Liver pathogenesis can result from dengue infection because of one or more of several potential insults, including direct viral or host immune response effects, on liver cells, compromised circulation and/or hypoxia caused by hypotension, localized vascular leakage inside the liver capsule, hepatotoxic effects of drugs such as acetaminophen, and the specific tissue tropisms of some viral serotypes or genotypes15.

Information on the use of blood transfusion products in children with dengue infection is scarce in the literature. In this study, the transfusion of at least 1 blood-based product was relatively common (15.4%) in patients admitted for suspected dengue infection, and 5 patients received more than 1 transfusion.

In this study, poor concordance existed between the classifications of dengue infection based on the medical diagnosis upon discharge and the WHO definitions. The reasons for low concordance between the medical diagnosis and the WHO classification are unknown; however, it appears that physicians have not applied a consistent and/or precise method to frame the signs and symptoms of dengue infection, which suggests a lack in knowledge regarding the criteria for dengue classification.

Despite limitations such as small sample size and the use of a single hospital for a retrospective analysis, this study concludes that a peculiar clinical profile is presented by children and adolescents with dengue infection at a reference center in northeast Brazil. In this setting, remarkable gastrointestinal symptoms and liver involvement were observed. To facilitate early and appropriate treatment and improved outcomes, physicians should be made aware of the clinical characteristics of dengue infection in children and adolescents.

CONFLICT OF INTEREST

The authors declare that there is no conflict of interest.

ACKNOWLEDGEMENTS

We are very grateful to the physicians, residents, and nurses of the São José Hospital of Infectious Diseases who provided both assistance to the patients in this study and the technical support needed to develop this research.

REFERENCES

1. Teixeira MG, Costa MC, Barreto F, Barreto ML. Dengue: twenty-five years since reemergence in Brazil. Cad Saude Publica 2009; 25 (supl I):7-18. [ Links ]

2. Cavalcanti LP, Vilar D, Souza-Santos R, Teixeira MG. Change in Age Pattern of Persons with Dengue, Northeastern Brazil. Emerg Infect Dis 2011; 17:132-134. [ Links ]

3. Cardoso IM, Cabidelle AS, Borges PC, Lang CF, Calenti FG, Nogueira LO, et al. Dengue: clinical forms and risk groups in a high incidence city in the southeastern region of Brazil. Rev Soc Bras Med Trop 2011; 44:430-435. [ Links ]

4. World Health Organization (WHO). Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization; 1997. [ Links ]

5. Ministério da Saúde. Secretaria de Vigilância em Saúde. Diretoria Técnica de Gestão. Dengue: diagnóstico e manejo clínico – Adulto e Criança. 3rd ed. Brasília: Ministério da Saúde; 2007. [ Links ]

6. Rocha LA, Tauil PL. Dengue em criança: aspectos clínicos e epidemiológicos, Manaus, Estado do Amazonas, no período de 2006 e 2007. Rev Soc Bras Med Trop 2009; 42:18-22. [ Links ]

7. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176:313-321. [ Links ]

8. Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop Med Int Health 2008; 13:1328-1340. [ Links ]

9. Aggarwal A, Chandra J, Aneja S, Patwari AK, Dutta AK. An epidemic of dengue hemorrhagic fever and dengue shock syndrome in children in Delhi. Indian Pediatr 1998; 35:727-732. [ Links ]

10. Hayes CG, Manaloto CR, Gonzales A, Ranoa CP. Dengue infections in the Philippines: clinical and virological findings in 517 hospitalized patients. Am J Trop Med Hyg 1988; 39:110-116. [ Links ]

11. Kabra SK, Jain Y, Pandey RM, Madhulika, Singhal T, Tripathi P, et al. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 1999; 93:294-298. [ Links ]

12. Kulkarni MJ, Sarathi V, Bhalla V, Shivpuri D, Acharya U. Clinico-epidemiological profile of children hospitalized with dengue. Indian J Pediatr 2010; 77:1103-1107. [ Links ]

13. Mohan B, Patwari AK, Anand VK. Hepatic dysfunction in childhood dengue infection. J Trop Pediatr 2000; 46:40-43. [ Links ]

14. Souza LJ, Nogueira RM, Soares LC, Soares CE, Ribas BF, Alves FP, et al. The impact of dengue on liver function as evaluated by aminotransferase levels. Braz J Infect Dis 2007; 11:407-410. [ Links ]

15. Seneviratne SL, Malavige GN, Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg 2006; 100:608-614. [ Links ]

Received: July 18, 2012; Accepted: February 5, 2013

Address to: Dr. Roberto da Justa Pires Neto. Depto Saúde Comunitária/FAMED/UFC. Rua Prof. Costa Mendes 1608/5° andar, Rodolfo Teófilo, 60430-140 Fortaleza, CE, Brasil. Phone: 55 85 3366-8044; Fax: 55 85 3366-8045. e-mail: robertojusta@ufc.br